Ad
related to: genmab us inc princeton- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Sign Up
Sign Up for Updates, News
and Much More.
- Careers
Search results
Results From The WOW.Com Content Network
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. [7] The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan.
Genmab was founded as a European spin-off of American Biotech company Medarex in February 1999. [10] The company was acquired by Bristol Myers Squibb in 2009 for $2.4 billion, which included $300 million in debt, making the payment to Medarex $2.1 billion. [11] [12]
Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands.
Epcoritamab, sold under the brand name Epkinly, is a monoclonal antibody anticancer medication used for the treatment of diffuse large B-cell lymphoma. [4] [7] Epcoritamab is a bispecific CD20-directed CD3 T-cell engager.
Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. [9] Daratumumab was granted breakthrough therapy drug status in 2013, for multiple myeloma.
Chairman, Genmab A/S , President of North America Pharmaceuticals for GlaxoSmithKline Deirdre P. Connelly (born in 1961) is a Puerto Rican business professional. [ 1 ] Connelly is Chairman of the Board of the European Biotech company Genmab A/S, member of the Boards of Macy’s Inc. and the Lincoln Financial Group.
It was established in 1988 with the primary location in Princeton, New Jersey and subsequently, a second location in the San Francisco Bay Area, specifically San Jose, California. The lab is a subsidiary of the NEC Corporation of America, headquartered in Irving, Texas. Its mission is to generate significant new knowledge and create innovative ...
Zealand Pharma A/S was founded by Bjarne Due Larsen, Lars Hellerung Christiansen, Leif Helth Jensen, Dan Buxbom, and Florian Schönharting in 1997 as Peptide Probe Technologies ApS, a biopharmaceutical company focused on the design and development of peptide-based medicine.
Ad
related to: genmab us inc princeton